MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.43, 2020 (SCI-Expanded)
Background: There aren't many reported skin changes associated with teriflunomide use in patients with multiple sclerosis (MS) mm Only one life-threatening gross skin change has been reported so far; a patient with toxic epidermal necrolysis. There are also a few case reports about cutaneous adverse effects of teriflunomide, such as eczema, rash and palmar pustular psoriasis. Methods: We herein report the first case of bullous drug reaction in a patient receiving teriflunomide treatment.